Search Results - "Gutting, Bradford W"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2
  3. 3

    Achieving consistent multiple daily low-dose Bacillus anthracis spore inhalation exposures in the rabbit model by Barnewall, Roy E, Comer, Jason E, Miller, Brian D, Gutting, Bradford W, Wolfe, Daniel N, Director-Myska, Alison E, Nichols, Tonya L, Taft, Sarah C

    “…Repeated low-level exposures to biological agents could occur before or after the remediation of an environmental release. This is especially true for…”
    Get full text
    Journal Article
  4. 4

    Dose-Response Modeling for Inhalational Anthrax in Rabbits Following Single or Multiple Exposures by Gutting, Bradford W., Rukhin, Andrey, Marchette, David, Mackie, Ryan S., Thran, Brandolyn

    Published in Risk analysis (01-11-2016)
    “…There is a need to advance our ability to characterize the risk of inhalational anthrax following a low‐dose exposure. The exposure scenario most often…”
    Get full text
    Journal Article
  5. 5

    Evaluation of Inhaled Versus Deposited Dose Using the Exponential Dose-Response Model for Inhalational Anthrax in Nonhuman Primate, Rabbit, and Guinea Pig by Gutting, Bradford W., Rukhin, Andrey, Mackie, Ryan S., Marchette, David, Thran, Brandolyn

    Published in Risk analysis (01-05-2015)
    “…The application of the exponential model is extended by the inclusion of new nonhuman primate (NHP), rabbit, and guinea pig dose‐lethality data for inhalation…”
    Get full text
    Journal Article
  6. 6

    Modeling low-dose mortality and disease incubation period of inhalational anthrax in the rabbit by Gutting, Bradford W., Marchette, David, Sherwood, Robert, Andrews, George A., Director-Myska, Alison, Channel, Stephen R., Wolfe, Daniel, Berger, Alan E., Mackie, Ryan S., Watson, Brent J., Rukhin, Andrey

    Published in Journal of theoretical biology (21-07-2013)
    “…There is a need to advance our ability to conduct credible human risk assessments for inhalational anthrax associated with exposure to a low number of…”
    Get full text
    Journal Article
  7. 7

    Nanoaerosols reduce required effective dose of liposomal levofloxacin against pulmonary murine Francisella tularensis subsp. novicida infection by Propst, Crystal N, Nwabueze, Albert O, Kanev, Igor L, Pepin, Rachel E, Gutting, Bradford W, Morozov, Victor N, van Hoek, Monique L

    Published in Journal of nanobiotechnology (18-04-2016)
    “…The Institute of Theoretical and Experimental Biophysics in Moscow recently developed a new nanoaerosol generator. This study evaluated this novel technology,…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    BALB/c mice orally pretreated with diclofenac have augmented and accelerated PLNA responses to diclofenac by Gutting, Bradford W, Updyke, Lawrence W, Amacher, David E

    Published in Toxicology (Amsterdam) (02-04-2002)
    “…The nonsteroidal anti-inflammatory drug (NSAID) diclofenac (DF) is associated with idiosyncratic hepatotoxicity and several other distinct hypersensitivity…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Investigating the TNP-OVA and direct popliteal lymph node assays for the detection of immunostimulation by drugs associated with anaphylaxis in humans by Gutting, Bradford W., Updyke, Lawrence W., Amacher, David E.

    Published in Journal of applied toxicology (01-05-2002)
    “…Using current animal models, it is not possible to identify low‐molecular‐weight compounds (LMWCs) that are likely to be associated with anaphylaxis. It is…”
    Get full text
    Journal Article
  13. 13

    Effect of animal sera on Bacillus anthracis Sterne spore germination and vegetative cell growth by Bensman, M.D., Mackie, R.S., Minter, Z.A., Gutting, B.W.

    Published in Journal of applied microbiology (01-08-2012)
    “…Aims:  The aims of this work were to investigate the effects of sera on B. anthracis Sterne germination and growth. Sera examined included human, monkey and…”
    Get full text
    Journal Article
  14. 14

    Diclofenac activates T cells in the direct popliteal lymph node assay and selectively induces IgG 1 and IgE against co-injected TNP–OVA by Gutting, Bradford W., Updyke, Lawrence W., Amacher, David E.

    Published in Toxicology letters (2002)
    “…Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently associated with immune-mediated hypersensitivity reactions. The NSAID diclofenac is associated…”
    Get full text
    Journal Article
  15. 15

    Diclofenac activates T cells in the direct popliteal lymph node assay and selectively induces IgG(1) and IgE against co-injected TNP-OVA by Gutting, Bradford W, Updyke, Lawrence W, Amacher, David E

    Published in Toxicology letters (28-05-2002)
    “…Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently associated with immune-mediated hypersensitivity reactions. The NSAID diclofenac is associated…”
    Get full text
    Journal Article
  16. 16

    A comparison of the direct and reporter antigen popliteal lymph node assay for the detection of immunomodulation by low molecular weight compounds by GUTTING, B. W, SCHOMAKER, S. J, KAPLAN, A. H, AMACHER, D. E

    Published in Toxicological sciences (01-09-1999)
    “…The direct popliteal lymph node assay (PLNA) is a predictive test used to detect the immune-stimulating potential of pharmaceuticals and other low molecular…”
    Get full text
    Journal Article